The 20 Best Schnitzler Syndrome Doctors near Berkeley Heights, NJ

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.

Dr. Markowski has been contributing to the field of oncology since working in a cancer research lab during and after his undergraduate work at Johns Hopkins University. A desire to care for patients brought him back to his home state of New Jersey where he completed his medical school degree at Rutgers-Robert Wood Johnson Hospital in New Brunswick, NJ. He then completed internal medicine residency and subsequent hematology/oncology fellowship training at Rutgers-Robert Wood Johnson Hospital/Cancer Institute of New Jersey.Throughout his hematology and oncology career Dr Markowski has published and presented many peer-reviewed articles, abstracts, and posters on a multitude of cancer types. He has particular interest and expertise in lung cancer, gastrointestinal cancers, and breast cancer. In addition, he has extensive experience taking care of patients with both benign and malignant blood disorders. Dr. Markowski is rated as an Advanced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Thrombocytopenia, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration.

Michael Wax is a Hematologist and an Oncologist in Berkeley Heights, New Jersey. Dr. Wax is rated as an Advanced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Non-Hodgkin Lymphoma, Myelodysplastic Syndrome (MDS), Gastric Lymphoma, and Polycythemia Vera. Dr. Wax is currently accepting new patients.

Lalitha Anand is a Hematologist and an Oncologist in Berkeley Heights, New Jersey. Dr. Anand is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Drug-Induced Thrombocytopenia, Thrombocytopenia, Desmoplastic Small Round Cell Tumor, and Anemia. Dr. Anand is currently accepting new patients.

Dr. Dennis Lowenthal has dedicated his career to caring for cancer patients, particularly those with lung cancer. He is the medical director of Medical Diagnostics Associates Hematology and Oncology, which is part of the Atlantic Medical Group. He also serves as medical director of Atlantic Health System’s Carol G. Simon Cancer Center at Overlook Medical Center.Growing up in the Bronx, NY, Dr. Lowenthal attended the State University of New York at Buffalo where he graduated magna cum laude with a BA in biology. He earned his medical degree at Boston University School of Medicine, continued with a medical internship at the Cleveland Clinic, and returned to the Bronx to complete his medical residency and a hematology fellowship at Montefiore Hospital and Medical Center of the Albert Einstein College of Medicine. He subsequently completed a clinical Blood Bank Directors fellowship at the New York Blood Center and then went on to complete a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center where he served as Chief Fellow and Special Clinical Fellow in AIDS-related malignancies.Dr. Lowenthal considers coming to Overlook Medical Center 32 years ago one of his best life decisions, working with his colleagues to help create the Carol G. Simon Cancer Center at Overlook Medical Center. He serves as chairman of the hospital’s Cancer Committee and Cancer Center Executive Committee, and has been the long-standing section chief for Hematology/Oncology. He is co-chairman of Thoracic Oncology and the Thoracic Tumor Board at Atlantic Health System and is the principal investigator for lung cancer clinical trials conducted at Overlook Medical Center – specifically, serving as the principal investigator for the first immunotherapy approved for the treatment of lung cancer. Dr. Lowenthal is a past recipient of Overlook’s Physician Excellence in Clinical Practice award and has been an associate professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, and currently the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Lowenthal is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and ALK-Positive Non-Small Cell Lung Cancer.

Usman Shah is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Lisa Mills is a Hematologist and an Oncologist in Berkeley Heights, New Jersey. Dr. Mills is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Childhood Iron Deficiency Anemia, Paget Disease of the Breast, Breast Cancer, and Myelodysplastic Syndrome (MDS). Dr. Mills is currently accepting new patients.

Jennifer Reeder is a Hematologist and an Oncologist in Berkeley Heights, New Jersey. Dr. Reeder is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Multiple Myeloma, and Thrombocytopenia. Dr. Reeder is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Advanced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Advanced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS).

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Matthew Stuart, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Dr. Stuart’s clinical interests include colorectal, pancreatic, gastrointestinal, lung, urological (GU) cancer, hematology, anemia, clotting disorders, lymphoma, multiple myeloma, and preventative care.Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, Dr. Stuart believes in treating the patient as a whole, implementing evidence-based, patient-centered, and cost-conscious care. His recent research includes evaluating race-based differences in treatment complications in patients with metastatic prostate cancer, improving vaccination rates in patients receiving chemotherapy, and providing community outreach to increase lung cancer screening and early detection.Dr. Stuart earned his medical degree at Rutgers New Jersey Medical School, Newark, NJ, where he served as director of the Student Family Health Care Center, the mini-medical school and premedical honors program, and the Institute for Public Understanding of Medicine in Action. He performed his internal medicine residency at Montefiore Medical Center, Bronx, NY, where he served on the Emergency-Internal Medicine and Resident Recruitment committees and received the Leo M. Davidoff Society Award for outstanding achievement in the teaching of medical students and a program innovation and improvement award. He remained at Montefiore to complete a fellowship in hematology/oncology, where he was named the chief hematology fellow and served on the Program Evaluation Committee. Following his fellowship training, he joined ACOHA in 2020.Fluent in conversational Spanish, Dr Stuart has presented at national and international medical conferences. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Stuart is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Colorectal Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration.

Beaula Koduri is a Hematologist and an Internal Medicine provider in Edison, New Jersey. Dr. Koduri is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Anemia, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Dehydration. Dr. Koduri is currently accepting new patients.

Anita Kumar is a Hematologist and an Oncologist in Basking Ridge, New Jersey. Dr. Kumar has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Mantle Cell Lymphoma (MCL), Gastric Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Kumar is currently accepting new patients.

David Gallinson is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gallinson is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Familial Colorectal Cancer, Anemia, Paget Disease of the Breast, Breast Cancer, and Bone Marrow Aspiration. Dr. Gallinson is currently accepting new patients.

Sarada Gurubhagavatula is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gurubhagavatula is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. Dr. Gurubhagavatula is currently accepting new patients.

Muhammad Abbasi is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Abbasi is rated as an Advanced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Abbasi is currently accepting new patients.

An expert in cancer care, Dr. Ellen Early brings broad-based knowledge and expertise to Atlantic Medical Group. She joins Atlantic Hematology Oncology, a growing team that is housed at Carol G. Simon Cancer Center at Morristown Medical Center. Board certified in internal medicine and medical oncology, Dr. Early diagnoses and treats cancer patients using a multidisciplinary approach, which includes radiation and surgical oncology and incorporates clinicians who work collaboratively to deliver the highest quality cancer care possible. In practice for over 25 years, Dr. Early has particular interest in caring for people with breast and lung cancers. Regarded by patients, families and colleagues for both her expertise and her compassion, Dr. Early strives to educate patients about their condition and discuss how to choose the best individualized treatment plan. Passionate about research, Dr. Early has participated in clinical trials throughout her professional career and utilizes chemotherapies, medications and targeted modalities to treat cancers of the breast and lung. After graduating from Saint Peter's University with a bachelor's of science in Biology, Dr. Early went on to achieve her master's degree in molecular biology at City University of New York in Brooklyn. She attended Georgetown University School of Medicine and performed both her internal medicine residency and her fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Dr. Early is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.